Denise Peterson
@PinkSheetDenise
Followers
1K
Following
489
Media
8
Statuses
1K
US biopharma editor at IBI Pharma (Pink Sheet and Scrip
Washington, D.C.
Joined April 2009
Time to spotlight folks doing great work in R&D strategy and trial design, including excellence in AI, diversity, RWE, and patient-facing technology. Nominate them for the Citeline Awards; deadline is now March 1.
citeline.com
2025 Citeline Awards in Boston: Honoring clinical trial excellence, tech advancements, and outstanding achievements in R&D. Join us for a celebration.
0
1
1
RT @ScripMandy: A holiday gift for anyone wondering what I was up to for @PharmaScrip at #ASH24 a few weeks ago: one of my long reads about….
insights.citeline.com
The first gene editing medicine and gene therapy for sickle cell disease were approved as the ASH meeting got under way, but novel oral drugs may be key to making treatment more accessible.
0
3
0
RT @PinkSheetSutter: @PharmaPinkSheet previously reported on sponsor's plans to contest withdrawal - get caught up here .
0
1
0
My comrade Brenda Sandburg several years ago profiled pioneering photojournalist Betty Steele, who died recently. Here’s an short – and wonderful – clip of Brenda interviewing Betty. Inspiring.
This clip shows some of Betty's amazing photos.
0
1
0
RT @KFFHealthNews: Join host @jrovner and panelists @shefalil, @SarahKarlin, and @AliceOllstein for a new health-packed ep. of #WTHealth! T….
kffhealthnews.org
A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market — rejecting a lower court’s decision to effectively cancel the drug’s FDA...
0
5
0
My TrialScope colleagues are benchmarking how biopharmas balance clinical trial reporting compliance/transparency with redacting sensitive company & patient data. If you’re involved in this area, help us out by taking this brief confidential survey:
surveymonkey.com
Take this survey powered by surveymonkey.com. Create your own surveys for free.
0
1
0
RT @SarahKarlin: More on the House Republican drug shortage bill this came from, from me last week:
0
1
0
Thomas Wicks, a Citeline colleague & trial transparency SME, is benchmarking how pharma is balancing transparency with needs to redact or anonymize some data. Help us out with our survey. #clinicaltrials #redaction #transparency.
surveymonkey.com
Take this survey powered by surveymonkey.com. Create your own surveys for free.
0
0
0
RT @PinkSheetSutter: A handy, quick reference for tracking industry lawsuits over the IRA's drug price negotiation provisions https://t.co….
insights.citeline.com
Access the latest regulatory and policy insights in the pharmaceutical industry with Pink Sheet. Stay informed on key updates, market trends, and developments.
0
3
0
RT @ScripRegVibha: Saudi FDA’s membership to PIC/s means that it can become a reference authority for inspecting pharmaceutical factories,….
0
2
0
RT @PinkSheetSutter: Wow - only 6 voting members on panel, 2 of whom are regular members of the PCNSDAC. In all my many many years of cover….
0
5
0
0
3
0
RT @dgingery: (2/2) And here is @PinkSheetSutter's look at Pepaxto from the FDA perspective . #PinkSheet #pharma:
0
1
0
RT @dgingery: (1/2) An interesting look at the saga of Pepaxto from our @ScripFrancesca and @PinkSheetSutter today. This is Francesca's loo….
0
1
0
RT @dgingery: More supplemental filings from me and @SarahKarlin . #pinksheet #pharma: Supplemental Filings: Pink Sheet Notebook On Disea….
0
3
0
RT @dgingery: Our take on yesterday's big neurology news from @PinkSheetSutter . #pinksheet #pharma: @US_FDA Neuroscience Office Director….
0
1
0
RT @dgingery: My analysis of the new OPT org chart . #Pinksheet #Pharma: CBER’s New Home For Gene Therapies: OTAT Changes To OTP But Lead….
0
1
0
RT @PinkSheetSutter: “We have these big societal issues and the decision about an individual product is like the tip of the spear of someth….
0
1
0
Our job opening for a Disclosure Regulations Research Manager is great for someone keen on the intersection of regulatory policy, clinical trials and patient engagement. More in our ad:
jobs.smartrecruiters.com
0
2
0